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Abstract: Several therapeutic products based on mesenchymal stem cells (MSCs) have been translated into clinical applications.
MSCs should undergo in vitro culture before a sufficient quantity can be achieved. Hence, both expansion kinetics and the biological
characteristics of derived cells from primary culture are pertinent to their applications. In the present study, MSCs were isolated from
rat bone marrow and adipose tissue (designated as bMSCs and aMSCs, respectively) and cells were comparatively analyzed regarding
cell morphology, proliferation, colony formation, differentiation potential, and immunophenotype following the long-term subculture.
No apparent differences could be noticed concerning the morphology between bMSCs and aMSCs. The long-term subculture made
both types of cells smaller, weakened their colony-forming ability, and stimulated the proliferation rate. However, bMSCs demonstrated
better proliferation and colony-forming ability than aMSCs. No significant difference was observed about the expression of some
immunophenotypes (i.e. CD29+/CD90+/CD34-/CD45-) regardless of cell types or population doublings. Notably, bMSCs, but not
aMSCs, maintained the differentiation potential well after the long-term subculture. The present study demonstrates that MSCs derived
from different tissues can be well expanded for the long term, although cells display gradually declined self-renewal and differentiation
potentials to different extents depending on the tissue origins.
Key words: Adipose tissue, bone marrow, comparative analysis, long-term culture, mesenchymal stem cells

1. Introduction
Regenerative medicine is a growing field that aims to treat
currently unmet clinical indications such as diabetes,
cardiovascular disease, and neurological disorders by
restoring or maintaining tissue function (Heathman et al.,
2015). Mesenchymal stem cells (MSCs) have tremendous
potential for applications in regenerative medicine due to
the abundant availability and potentials of self-renewal
and differentiation (Lim et al., 2016). Since Pittenger et al.
demonstrated that human bone marrow-derived MSCs
could be successfully induced to undergo multilineage
differentiation in 1999 (Pittenger et al., 1999), thousands
of studies have been carried out with the objective of
translating MSCs in clinical settings. Moreover, MSCs
have been discovered to bear the capability of secreting
a plethora of bioactive factors that are involved in
immunomodulation, chemotaxis, apoptosis, antifibrosis,
etc. (Mizukami et al., 2016). It was also reported that MSCs
that survived in vivo had the characteristics of pericytes
and could maintained vasomotion, vascular maturation,
and regulation of extracellular matrix turnover through
mechanisms similar to the signal transduction between
paracrine and other tissues (Dijk et al., 2015). According
to the latest update at ClinicalTrials.gov, there were

>800 trials registered related to MSCs as of 15 July 2018.
To date, a few therapeutic MSCs products, including
Prochymal (Osiris), ChondroyCelect (TiGenix), and MPC
(Mesoblast), have been approved for clinical application
in the United States, Europe, and Australia, respectively.
In Korea, Hearticellgram (FCB-Pharmicell) and Caristem
and Cuepistem (Osiris) were also made available in clinics.
These products are used for the treatment of graft-versushost disease, cartilage injury, acute myocardial infarction,
Crohn disease, etc.
Although the successful application of MSCs in clinical
settings has become a reality, there are still many challenges
associated with developing MSCs-based therapeutic
products, especially concerning the production process
of cell products. The MSCs culture specifics, including
methods of isolation, expansion, cell enrichment, cell
storage, and procedures for adherent or suspension cultures,
play an important role in the production of MSCs-based
products (dos Santos et al., 2013). A strictly controlled
process is the prerequisite for both safety and efficacy of
MSCs-based products and the establishment of a standard
protocol that meets the guidelines of good manufacturing
procedures remains unresolved. In clinical treatment, cellbased therapy requires a high number of MSCs, typically
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more than one million cells per kilogram of the patient’s
body weight. Given the extremely low frequency of MSCs
of tissue origins (Fuchs et al., 2004), an efficient ex vivo
expansion process is required to attain such a large dose of
cell products. In addition, in the case of developing one onthe-shelf cell product for many individuals, an even larger
quantity of cells is anticipated from one tissue sample.
However, the challenge is that cells are very unique on
their own, which places a hurdle for developing a general
production process of all cell products. The expansion
characteristics can be drastically varied related to the
developmental stage of the cell’s tissue of origin, species,
culture process, and so on (Deasy et al., 2005). Moreover,
numerous studies have demonstrated that the growth rate,
phenotype, and differentiation potential of MSCs can be
altered after long-term culture, which definitely would
exert great influences on the therapeutic effects of end
products (Bara et al., 2014). For instance, several studies
demonstrated that the expression of senescence-associated
β-galactosidase (SA β-gal, a senescence marker) in MSCs
increased after long-term culture, which led to gradual
senescence of MSCs (Li et al., 2012; Gu et al., 2016). Others
indicated that MSCs sustained prolonged self-renewal
and homogeneous characteristics for over 50 passages
without losing their differentiation potential (Meirelles and
Nardi, 2003). However, understanding of the effects of in
vitro expansion on the characteristics of MSCs remains
in its infancy, which is critical to cell-based therapeutic
applications and warrants further thorough investigation.

An optimal source of MSCs for in vitro expansion
is critical for developing cell-based therapeutics as
MSCs can be derived from various tissues, such as bone
marrow, umbilical cord blood, adipose tissue, etc. MSCs
from different tissues display significant differences in
characteristics and functions (Chen et al., 2015). For
instance, bone morrow-derived MSCs (bMSCs), the earliest
discovered and defined MSCs, showed a better proliferative
capacity than other types of MSCs (dos Santos et al., 2014).
While in the past few decades, bMSCs have attracted great
attention, the harvest of bone marrow is a highly invasive
procedure. Umbilical cord blood is an alternative choice,
which can be obtained by a less invasive method, without
harm for the mother or the infant. However, whether
full-term umbilical cord blood can serve as a source for
isolating MSCs still remains controversial (Mareschi et al.,
2001), and MSCs derived from umbilical cord blood might
be inefficient in undergoing adipogenesis (Kern et al.,
2006). Additionally, it is only limited to newborns. Adipose
tissue represents a very attractive source of MSCs, due to its
easy accessibility with a less invasive method (Kanth et al.,
2015; Nishigaki et al., 2017).
Source-dependent and donor-dependent differences of
MSCs properties, including implications on their clinical
application, are still largely unknown. In the present study,
our aim is to comparatively assess the properties of MSCs
isolated from adipose tissue and bone marrow and the
effects of long-term ex vivo expansion on these MSCs.
As illustrated in Figure 1, rat bMSCs and adipose tissue-

Figure 1. Schematic illustration of cell isolation and subculture processes.
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derived MSCs (aMSCs) were isolated and cell morphology,
proliferation, colony formation, differentiation capacity,
and immune phenotype were examined for these cells
during long-term culture.
2. Materials and methods
2.1. Isolation and primary culture of bMSCs and aMSCs
Bone marrow and adipose tissue were from 4-weekold male Sprague Dawley rats purchased from Shanghai
Slac Laboratory Animal Co. All animal experimental
procedures were performed in accordance with the
guidelines for the care and use of laboratory animals at the
Shanghai Laboratory Animals Center and the protocols
were approved by the Institutional Animal Care and Use
Committee of Shanghai Laboratory Animal Center.
Rat bMSCs were isolated as illustrated in Figure 1 as
described by Huang et al. (2015). Briefly, the rat’s hind
limb femur and tibia were harvested, and after removal
of the peripheral muscle tissue, both femur and tibia were
soaked with alcohol briefly and then rinsed twice with
phosphate-buffered saline (PBS) containing 1% penicillin/
streptomycin. Both ends of the epiphyseal were pinched off
with a broken bone clamp and bone marrow was flushed
out with α-minimum essential medium alpha medium
(α-MEM, GIBCO) containing 10% fetal bovine serum (FBS,
Biosun) until the flushing medium turned from brown to
an orange-red color. The bone marrow suspension was
filtered with a 200-mesh sieve and then centrifuged. The
pellets were resuspended in growth medium composed
of α-MEM supplemented with 10% FBS, and cells were
plated in T25 flasks followed by incubating at 37 °C and
5% CO2. Initial medium refreshment was performed after
48 h and, after that, the medium was changed every 3 days
until cells reached 80%–90% confluence.
Rat aMSCs were isolated as illustrated in Figure 1 as
described previously (Sugii et al., 2011). Rat bilateral
inguinal adipose tissues were taken and soaked in alcohol
briefly. After rinsing with PBS containing 1% penicillin/
streptomycin twice, adipose tissue was minced into
small pieces and then treated with 2% collagenase II
(Invitrogen) on a shaker at 120 rpm at 37 °C and 5% CO2
in an incubator. After 60 min, adipose tissue fragments
turned into a thin cloud and mist and growth medium
with 10% FBS was added to stop enzymatic digestion. The
suspension was further pipetted 30–40 times and then
filtered with 65-mesh and 150-mesh sieves in turn. The
filtrate was centrifuged for 5 min at 1500 rpm and then
the upper ﬂoating layer containing mature adipocytes
and aqueous supernatant was carefully aspirated to obtain
cell pellets, which were composed of stromal vascular
fraction cells. The pellet was resuspended in 10 mL of PBS
and cells were plated in T25 flasks in α-MEM with 10%
FBS followed by incubating at 37 °C and 5% CO2. Initial

medium refreshment was performed after 48 h and, after
that, the medium was changed every 3 days until cells
reached 80% to 90% confluence.
2.2. Long-term culture of bMSCs and aMSCs
Both bMSCs and aMSCs were subcultured until passage
3 and then used for subsequent long-term culture
experiments. To initiate the long-term culture, bMSCs or
aMSCs of passage 3 were plated at 5000 cells/cm2 in T25
flasks in growth medium. When cells reached 80% to 90%
confluence, they were harvested via enzymatic treatment
with 0.25% trypsin/EDTA (GIBCO), counted, and
subcultured at 5000 cells/cm2 in T25 flasks. This process
was repeated until 40 passages were achieved. During
culture, the medium was refreshed every 3 days. For each
passage, population doubling (PD), population doubling
time (PDT), and cumulative population doublings (CPDs)
were calculated based on cell counting and culture time
based on the following equations, respectively:

Here, n is passage number, N0 is cell number at seeding,
Nn is cell number of the nth passage at harvesting, PDn is
population doubling of the nth passage, and T is culture
time in the respective passage.
In addition, at early passages, bMSCs or aMSCs plated
in 24-well plates at 5000 cells/cm2 were also counted every
other day and the growth curves were plotted for each
passage of cells.
2.3. F-actin staining
Cell morphology was evaluated by F-actin staining. In 24well plates, bMSCs or aMSCs of passage 4 or 40 were plated
at 5000 cells/cm2 and, after 24 h, cells were rinsed with PBS,
fixed with 4% paraformaldehyde in PBS, and permeated
with 0.1% Triton X-100 in PBS. After rinsing with PBS
again, cells were treated with 2 μg/mL DAPI (Invitrogen)
and 5 μg/mL rhodamine phalloidin (Invitrogen) for 30
min in the dark. Cells were observed and photographed
under an inverted fluorescence microscope (Eclipse Ti-S,
Nikon).
2.4. Colony formation assay
The frequency of colony-forming unit fibroblasts (CFUFs) for bMSCs or aMSCs was determined by colony
formation assay. Cells of passage 4, 13, or 40 were plated
in 6-well plates at 100 cells/well and the medium was
refreshed twice a week. After 2 weeks, cells were rinsed
with PBS, fixed with 4% paraformaldehyde in PBS, and
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stained with 0.1% crystal violet for 30 min. After rinsing
with PBS again, the number of CFU-Fs was counted. All
assays were performed in 6 replicates.
2.5. Flow cytometric analysis
Flow cytometry was applied to study the immunophenotype
of cells. Approximately 1 × 106 bMSCs or aMSCs at
different passages were harvested and resuspended in
growth medium to prepare single-cell suspensions. Cell
preparations were incubated with 1 μg of the specific
antibodies or corresponding isotype control antibodies
as shown in the Table for 30 min at 4 °C in the dark. For
CD73, the nonfluorescence labeled primary antibody, cell
preparations were subsequently treated with the secondary
antibody, FITC rat antimouse IgG1 (BD), for 30 min at 4
°C. All cell preparations were analyzed by flow cytometry
(FACSCalibur, BD) and data analysis was performed with
FlowJo software (Tree Star).
2.6. Induction of linage-specific differentiation
Evaluation of the differentiation potential of MSCs towards
osteogenesis and adipogenesis was performed as described
previously. Briefly, bMSCs or aMSCs were plated in 24-well
plates at 1000 cells/cm2 and maintained in growth medium
until 80% to 90% confluence. For osteogenic induction,
cells were exposed to osteogenic induction medium
composed of DMEM-HG supplemented with 10% FBS, 10
mM sodium β-glycerophosphate, 50 mg/L L-diphosphate
ascorbic acid, 0.1 μmol/L dexamethasone, and 1%
penicillin/streptomycin, and for adipogenic induction,
cells were incubated in adipogenic induction medium
of DMEM-HG supplemented with 10% FBS, 10 mg/L
insulin, 0.1 mmol/L IBMX, 0.1 mmol/L indomethacin, 1
μmol/L dexamethasone, and 1% penicillin/streptomycin.
After induction for 7, 14, or 21 days, cells were fixed
with 4% paraformaldehyde in PBS. To assess osteogenic

differentiation, cells were stained with Alizarin Red S
(Sigma-Aldrich), and to assess adipogenic differentiation,
lipid vacuoles in differentiated cells were stained using Red
Oil O (Sigma-Aldrich).
2.7. Statistical analysis
Quantitative data were reported as averages ± standard
deviations, unless otherwise stated. Statistical analyses
were performed using Student’s t-test (GraphPad Software)
and P < 0.05 was considered statistically significant.
3. Results
3.1. Morphological characterization of cells in primary
and long-term cultures
Primary cell culture was initiated after the bone marrow
suspension was centrifuged and adipose tissue was
enzymatically digested to release cells. During the
culturing process, cells were observed and photographed
under a phase-contrast microscope. In terms of cells
from bone marrow, most cells were round on day 2, and
only a few cells appeared elongated in shape (Figure 2A,
red arrow). With prolonged culture time, the spindleshaped cells reached 50%–60% confluence on day 5 and
~90% confluence on day 8. For cells derived from adipose
tissue, far fewer cells were present on day 2 and some
spindle-shaped cells appeared on day 5 (Figure 2A, yellow
arrow). On day 14, the spindle-shaped cells reached ~90%
confluence. Therefore, for rats, bone marrow contained
many more adhered cells in primary culture than inguinal
adipose tissue.
Following subculture once (i.e. passage 1), both
cultures contained cells with various shapes, such as round,
polygonal, and elongated cells. After further subculture,
at passage 4, cells displayed a uniform fibroblast-like
morphology and tended to follow an ordered, aligned

Table. Antibody specifics for flow cytometric analysis.
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Antigen

Primary antibody

Secondary
antibody

Isotype control antibody

Source

CD29

FITC Hamster antirat CD29

--

FITC hamster IgM , λ1

BD

CD105

Alexa Fluor 405 mouse antirat/human
CD105

--

Alexa Fluor 405
mouse IgG2A

Novus
Biologicals

CD73

Purified mouse antirat CD73

FITC rat
FITC rat IgG1, κ
antimouse IgG1

BD

CD44

FITC-conjugated mouse antirat CD44

--

FITC mouse IgG1

Abd Serotec

CD106

FITC-conjugated mouse antirat CD106

--

FITC mouse IgG1

Abd Serotec

CD90

FITC-conjugated mouse antirat CD90

--

FITC mouse IgG1, κ

BD

CD45

FITC-conjugated mouse antirat CD45

--

FITC mouse IgG1, κ

BD

CD34

Alexa Fluor 488 rabbit antirat CD34

--

Alexa Fluor 488 rabbit IgG1

Abcam
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Figure 2. The morphology of bMSCs and aMSCs in primary and long-term cultures. A) Phase-contrast images of primary culture after
different time intervals. The cells pointed out by the red arrow and the yellow arrow are spindle-shaped bMSCs and aMSCs, respectively.
B) phase-contrast images after 6 days in culture at different passages. The cells pointed out by the red arrow and the yellow arrow are
rounded cells and oval cells, respectively. C) Fluorescence images of F-actin staining after 24 h in culture at passages 4 and 40.
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arrangement. At passage 13, bMSCs and aMSCs became
shorter and wider and sparse nodules of clustered cells
showed up in culture. At passage 21, some polygonal cells
appeared in bMSCs (Figure 2B, red arrow) and cobblelike cells in aMSCs (Figure 2B, yellow arrow). Almost
all bMSCs and aMSCs turned cobble-like at passage 40
and bMSCs were in general elongated more than aMSCs.
These data suggested that during the long-term culture, the
morphology of both bMSCs and aMSCs evolved following
subculture.
In order to observe cell morphology more clearly,
the cytoskeleton of bMSCs and aMSCs at passages 4
and 40 was further analyzed by F-actin staining. As
shown in Figure 2C, at 24 h, bMSCs and aMSCs were
spread out and uniformly distributed. DAPI-stained cell
nuclei showing blue fluorescence located in the center
of cells and myofilament proteins as indicated in red
fluorescence. Both bMSCs and aMSCs of passage 4 were
large and showed a triangular or polygonal morphology.
However, both bMSCs and aMSCs at passage 40 become
smaller and displayed small, round, spindle, or polygonal
morphologies. No apparent difference in morphology
between bMSCs and aMSCs was noted.
3.2. Long-term subculture of bMSCs and aMSCs
At the early passages (before passage 7), the growth kinetics
of bMSCs and aMSCs were as shown in Figures 3A and 3B,
respectively. In general, both cell types demonstrated great
proliferative potential at all different passages, showing a
drastic increase in cell number with culture time within
each passage. However, the growth profiles varied among
different passages for both cell types. For bMSCs, within the
first 6 days in culture at all examined passages, the growth
rates increased with the increase of passage number, and
after day 6, cells at passage 7 reached a stable plateau while
cells at other passages were still in a proliferative state
until day 16. For aMSCs, cells at passages 3 and 7 shared
a similar profile with a slow proliferation rate, reaching
the plateau after 14 days in culture. In contrast, aMSCs
at passages 4 and 6 displayed much faster growth within
the first 8 days in culture and then reached the plateau.
As shown in Figure 3C, after 16 days of culture, bMSCs
at passages 3, 4, 6, and 7 had expanded 16.5 ± 0.5, 37.0
± 1.2, 48.4 ± 0.6, and 30.8 ± 0.3 times, respectively, while
aMSCs had expanded 19.4 ± 1.1, 20.9 ± 4.3, 23.8 ± 0.6,
and 13.8 ± 1.6 times, respectively. These data suggested
that within passage 7, the initial subculture promoted cell
proliferation and cell proliferative potential declined with
extended subculture for early passages of cells. Moreover,
bMSCs had higher proliferative potential than aMSCs.
Furthermore, the proliferation characteristics (i.e. PD,
CPD, and PDT) of MSCs were analyzed during the longterm subculture for a total of 220 days. Overall, bMSCs and
aMSCs underwent a significant expansion of 158 and 142

482

PD, respectively (Figure 3D), suggesting great proliferative
potential for both cell types. In other words, 2.8 × 1051 cells
and 4.1 × 1046 cells could be obtained from 5000 cells of
bMSCs and aMSCs at passage 3, respectively. Thus, a much
greater quantity of MSCs could be acquired from the same
starting seed cell number for bMSCs than aMSCs. PDT
was further calculated to analyze the growth rate of cells
at each passage. In general, the PDT of bMSCs and aMSCs
decreased drastically from 3.0–4.5 days to 1.5–2.5 days
within 30 days, followed by a steady decrease to 1.0–2.0
days until the end of the long-term subculture (Figure 3E).
However, at the early stage (<40 days), the PDT of aMSCs
was greater than that of bMSCs, indicating that during this
period, bMSCs proliferated better than aMSCs. Following
extended subculture, the PDT of bMSCs became slightly
higher than that of aMSCs between 70 and 120 days and
this trend was then reversed after 120 days of subculture.
Hence, it was demonstrated that both bMSCs and aMSCs
had great proliferative potential during long-term
subculture and tended to expand faster with subculturing.
3.3. Colony-forming capability of bMSCs and aMSCs after subculture
As defined, MSCs should be able to form single cellderived colonies when plated at a low density (Colter et
al., 2000). The CFU-Fs assay is often applied to determine
the self-renewal potential of stem cells. At different
passages, CFU-Fs of bMSCs and aMSCs were recorded
and compared. As illustrated in Figure 4A, after 14 days
of culture at a low density of 10 cells/cm2, positive crystal
violet staining was detected for both bMSCs and aMSCs
at passages 4 and 13, suggesting that bMSCs and aMSCs
had self-renewal potential. Notably, as shown in Figure
4B, at both passages 4 and 13, the numbers of CFU-Fs
for bMSCs were significantly higher than those of aMSCs
(43.7 ± 2.4 vs. 36.7 ± 2.8 at passage 4; 28 ± 2.4 vs. 20.2 ± 2.6
at passage 13). Furthermore, compared to those at passage
13, both types of MSCs at passage 4 had a statistically
higher number of CFU-Fs. Interestingly, for bMSCs and
aMSCs at passage 40, the crystal staining diffused all over
the plate, possibly due to rapid cell proliferation, such that
it became impractical to count CFU-Fs accurately. These
data demonstrated that both bMSCs and aMSCs preserved
the self-renewal potential following subculture and bMSCs
were better than aMSCs at self-renewal.
3.4. Lineage-specific differentiation of bMSCs and aMSCs
The differentiation potential of bMSCs and aMSCs
following long-term subculture was characterized
regarding the osteogenic and adipogenic differentiation.
As shown in Figure 5, after the osteogenic and adipogenic
induction, formations of calcium-rich mineralized
nodules and intracellular lipid vacuoles were detected
by Alizarin Red S and Oil Red O staining, respectively.
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It was found that bMSCs at passage 13 were much more
efficient in depositing the mineralized matrix on days
7 and 14 than those at passages 4 and 40. After 21 days
of induction, bMSCs at all passages showed very strong
Alizarin Red S staining. In contrast, bMSCs were prone to
undergo adipogenic differentiation into mature adipocytes
at passages 4 and 40, but not at passage 13. Interestingly,
the efficiency of calcium deposition for aMSCs showed no
apparent difference at different passages. However, while

Time (days)

aMSCs displayed positive staining of Oil Red O at passage
4, lipid vacuoles could not be discerned at passages 13
and 40 within 21 days of induction. Together, bMSCs
maintained their differentiation potential after long-term
subculture and aMSCs lost the adipogenic differentiation
upon subculture.
3.5. Immunophenotype of bMSCs and aMSCs
To further characterize MSCs, cell surface marker proteins
of bMSCs and aMSCs were examined by flow cytometric

Time (days)

Time (days)

Time (days)
Figure 3. Growth characteristics of bMSCs and aMSCs during subculture. A) The growth curves of bMSCs at early passages. B) The
growth curves of aMSCs at early passages. C) The expansion folds of bMSCs and aMSCs at early passages. D) CPD during long-term
subculture. E) PDT during long-term subculture. *: P < 0.05 compared to aMSCs (n = 3).
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Figure 4. CFU-Fs of bMSCs and aMSCs. At different passages, bMSCs and aMSCs were plated in 6-well plates at 100 cells/well for 2
weeks and then stained with crystal violet. A) Images of crystal violet staining; B) quantification of CFU-Fs. ND: Not detected; *: P <
0.05 (n = 6).

analysis. As shown in Figure 6, both bMSCs and aMSCs at
passage 4 had no expression of hematopoietic progenitor
cell marker CD34, panleukocyte marker CD45, or
endoglin marker CD105, and more than 97% of both cell
types expressed typical MSCs marker proteins including
CD29 (integrin 1 chain) and CD90 (Thy-1). While CD44
and CD73 were present in both bMSCs and aMSCs, the
percentage of CD44+ bMSCs was significantly larger
than that of CD44+ aMSCs (94.3% vs. 46.0%) and the
percentage of CD73+ cells was much greater for aMSCs
than bMSCs (94.2% vs. 12.9%). Remarkably, 10.3% of
bMSCs were found to express CD106 (vascular cell
adhesion molecule-1, VCAM-1), which was not detected
in aMSCs. At passage 40, the expression of CD29, CD90,
CD34, and CD45 for both bMSCs and aMSCs was not
distinct from that at passage 4. However, almost no
expression of CD44 and CD73 and positive expression of
CD105 (15.6% in bMSCs and 58.5% in aMSCs) was found
at passage 40. Moreover, 21.2% of aMSCs became positive
for CD106, while no significant difference was seen for
bMSCs between passages 4 and 40. Collectively, long-term
subculture could affect the immunophenotype of both
bMSCs and aMSCs.
4. Discussion
In the present study, bMSCs and aMSCs were isolated
from rats and then subjected to adherent subculturing.
These cells were characterized in parallel to confirm their
identity as authentic MSCs concerning cell morphology,
proliferation, multilineage differentiation potential,
colony-forming capability, and immunophenotyping
during a long-term culture of 220 days. It was found that
both bMSCs and aMSCs demonstrated similar typical
fibroblast-like morphology in primary culture and the
long-term culture made both types of cells smaller.
Importantly, both cell types had great proliferative potential
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and grew faster following the continuous passaging. The
colony formation ability of both types of MSCs and the
differentiation potential of aMSCs decreased following
subculture. In general, bMSCs showed greater potential
in cell proliferation, colony formation, and differentiation.
Moreover, the distinct expression of CD44, CD73, and
CD106 was noticed between bMSCs and aMSCs and the
long-term subculturing affected the expression of several
surface markers, especially CD105, CD44, and CD73. This
comparative study offers new insights into the differences
between bMSCs and aMSCs, which have not been reported
before.
MSCs-derived bone marrow and adipose tissue are
most widely studied and applied in clinical settings.
Current protocols for isolating aMSCs are mainly based on
enzymatic digestion of adipose tissue samples, followed by
adherent culture (Estes et al., 2010; Sugii et al., 2011). For
bMSCs, there are two most frequently applied methods,
namely direct adherent culture based on differential
adhesive properties of different cell types in bone marrow
cell preparation (Huang et al., 2015) and density gradient
purification followed by adherent culture (Sung et al., 2008).
However, Bortolotti et al. (2015) reported that bMSCs
isolated by the former method tended to preserve better
cell viability and paracrine secretion. For a straightforward
comparison between bMSCs and aMSCs, cells were
derived from bone marrow and adipose tissue preparations
via direct adherent culture in the present study.
MSCs normally display fibroblast-like spindle shape
in culture. However, the rat MSCs isolated in the present
study were shorter and wider than those from humans
(Sugii et al., 2011), rabbits (Lee et al., 2014), and goats
(Mohamadfauzi et al., 2015), but consistent with rat or
mouse MSCs as reported by others (Peng et al., 1995;
Huang et al., 2015). Moreover, bMSCs and aMSCs showed
similar shapes in the present study and both slightly
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Figure 5. Differentiation of bMSCs and aMSCs. At different passages, bMSCs and aMSCs were cultured in osteogenic and adipogenic
induction media for 21 days and stained with Alizarin Red S and Oil Red O on day (d) 7, 14, and 21, respectively.

transformed with culture time. Hence, the morphology of
MSCs varies among species, but not tissue origins.
The self-renewal potential of MSCs was evaluated
via long-term subculturing for 220 days. First, cell
proliferation was characterized for both MSCs and
compared. The proliferation rate of bMSCs and aMSCs
increased first, then decreased, and finally stabilized
following subculture during the whole culture period. This
may have been caused by the increasing level of SA β-gal
following the long-term subculture (Li et al., 2012; Gu
et al., 2016) or the changing of passage-specific proteins
(Çelebi et al., 2009). Nonetheless, bMSCs had a stronger
capability to proliferate within early (<40 days) and late
stages (>120 days) of subculturing than aMSCs, which
was not consistent with results for human bMSCs and
aMSCs (Guneta et al., 2016). This discrepancy may be
due to different starting cell densities applied in different
studies (Meirelles and Nardi, 2003), or species-specific
differences. Within a total of 220 days, both bMSCs and

aMSCs achieved about 150 PD (>1 × 1045 cells), indicating
the sustainable potential of self-renewal during ex vivo
expansion. In applying MSCs in clinical settings, a quantity
of 1 × 109 cells is generally required, thus making both
bMSCs and aMSCs promising in therapeutic applications.
Second, colony-forming capability, an important index
of self-renewal, was analyzed for bMSCs and aMSCs. It
was found that both cell types showed declined colonyforming capability following passaging before passage 13,
and bMSCs generally had higher CFU-Fs as compared
to aMSCs. Third, the lineage-specific differentiation was
assessed. While bMSCs maintained the multipotent
potential of differentiating into osteoblasts and adipocytes
following long-term subculture, aMSCs displayed no
adipogenic differentiation after 32 PD. Meirelles and Nardi
(2003) reported that murine bMSCs could sustain selfrenewal and multipotent potential for over 50 passages
(equivalent to ~150 PD, over 8 months). Muraglia et al.
(2000) as well as Gu et al. (2016) demonstrated that human
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Figure 6. Analysis of surface makers of bMSCs and aMSCs. At passages 4 and 40, bMSCs and aMSCs were cultured for 5 days and then
subjected to flow cytometric analysis to detect the expression of various surface markers.
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bMSCs lost the adipogenic differentiation capacity after
extended subculturing (22 PD). However, the present
study represents the first study to compare between bMSCs
and aMSCs. The loss of the differentiating potential of
aMSCs after long-term subculture represents a limiting
factor in using these cells in therapeutic applications.
Some unspecified proteins may be responsible for the loss
of differentiation potential of aMSCs (Çelebi et al., 2009).
Supplementation of factors such as FGF-2 (Bianchi et al.,
2003), TGF-β, and PGE2 (Wu et al., 2016) during expansion
culture of MSCs may be an effective way to ameliorate this.
Further, the immunophenotype of bMSCs and aMSCs
was study by flow cytometric analysis of surface molecular
markers during the long-term culturing. Overall, both
bMSCs and aMSCs ubiquitously expressed CD29 and
CD90 and did not express CD34 and CD45 independent
of passages. This is consistent with the reported cell surface
marker profile of rat bMSCs (Ran et al., 2009), as well as the
definition of human MSCs by the International Society for
Cellular Therapy (ISCT) (Dominici et al., 2009). However,
neither bMSCs nor aMSCs expressed CD105 at passage
4, which is apparently inconsistent with some reports
(Marappagounder et al., 2012; Otte et al., 2013) as well
as the definition of human MSCs by the ISCT. However,
the expression of CD105 in rabbit MSCs was found
undetectable in one study (Lee et al., 2014). Moreover, low
to no expression of CD105 was also reported in human
MSCs (Li et al., 2012; Tancharoen et al., 2017). Hence, the
expression of surface markers can in fact be dependent on
several factors such as the species as well as the process

protocols. Intriguingly, following subculture, bMSCs
and aMSCs showed a fairly noticeable declination in the
expression of CD44 and CD73, but upregulation of CD105.
Only late-passage aMSCs showed an increased expression
of CD106. These changes in the immunophenotype of
MSCs may affect their functions (Bara et al., 2014). For
instance, CD105- MSCs exhibited enhanced adipogenic
potential (Jiang, et al. 2010; Anderson, et al., 2013); it has
been suggested that the expression of CD106 on MSCs
might be linked to the lineage-specific differentiation
potential of MSCs (Fukiage et al., 2008; Chen et al., 2015).
In the present study, MSCs were isolated from rat bone
marrow and adipose tissue and subjected to a long-term
subculture for 220 days. Within 220 days, both bMSCs
and aMSCs demonstrated varying proliferation rate,
colony-forming capability, multilineage differentiation
potential, and immunophenotype with the subculturing.
While both types of MSCs proliferated faster following the
long-term subculture, bMSCs showed higher proliferation
rate, colony-forming capability, and multilineage potential
compared to aMSCs. These results highlight the profound
differences in characteristics and functions of MSCs
derived from different tissue origins.
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